Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Contraception and Contraceptive Drugs

Free Subscription Articles published in Obstet Gynecol Retrieve available abstracts of 53 articles: HTML format

Single Articles

April 2026
1. KIRKPATRICK L, Harrison EI, Al-Faraj AO, Betstadt SJ, et al
   Epilepsy, Intellectual and Developmental Disabilities, and Contraception in U.S. Medicaid Claims Data.
   Obstet Gynecol. 2026 Apr 9. doi: 10.1097/AOG.0000000000006281.
   PubMed     Abstract available
   
   
   February 2026
2. SRIPRASERT I, Hodis HN, Mack WJ, Rosser M, et al
   Elimination of the Black Box Warning on Menopausal Hormone Therapy.
   Obstet Gynecol. 2026 Feb 13. doi: 10.1097/AOG.0000000000006226.
   PubMed     Abstract available
   
   
   November 2025
3. 
   ACOG Committee Statement No. 21: Access to Contraception.
   Obstet Gynecol. 2025;146:e88-e97.
   PubMed     Abstract available
   
   
   August 2025
4. PEARSON A, Shvartsman K, Zeng W, Brown J, et al
   Cost Effectiveness of Salpingectomy Compared With Vasectomy for Permanent Contraception.
   Obstet Gynecol. 2025 Aug 28. doi: 10.1097/AOG.0000000000006042.
   PubMed     Abstract available
   
   
   
5. KUMASAKA JK, Mandelbaum AD, Edelman AB, Caughey AB, et al
   Cost Effectiveness of Over-the-Counter Availability of Progestin-Only Contraceptive Pills in Abortion-Restrictive and Abortion-Protective Settings.
   Obstet Gynecol. 2025 Aug 21. doi: 10.1097/AOG.0000000000006048.
   PubMed     Abstract available
   
   
   June 2025
6. ARORA KS, Larkin S, Milne J, Carmona Clavijo G, et al
   Goals and Priorities of Community Members Regarding the Federally Mandated Medicaid Sterilization Policy.
   Obstet Gynecol. 2025;146:394-401.
   PubMed     Abstract available
   
   
   May 2025
7. SMEREKA MI, Vivas-Valencia C, Testa A, Byrne JJ, et al
   Expanding Access to Quality Reproductive Health Care After the Dobbs v. Jackson Women's Health Organization Decision.
   Obstet Gynecol. 2025;146:195-201.
   PubMed     Abstract available
   
   
   
8. KOU L, Huang C, Xiao D, Liao S, et al
   Pharmacologic Interventions for Endometriosis-Related Pain: A Systematic Review and Meta-analysis.
   Obstet Gynecol. 2025 May 15. doi: 10.1097/AOG.0000000000005923.
   PubMed     Abstract available
   
   
   March 2025
9. YUK JS, Kim MH, Yoon SH, Han GH, et al
   Association Between Levonorgestrel-Releasing Intrauterine System Exposure Duration and Breast Cancer Incidence.
   Obstet Gynecol. 2025 Mar 13. doi: 10.1097/AOG.0000000000005881.
   PubMed     Abstract available
   
   
   February 2025
10. CARMODY MD, Schultz AL, Berg KA, Bullington BW, et al
    Association Between Comorbidities and Inpatient Postpartum Permanent Contraception Completion.
    Obstet Gynecol. 2025 Feb 6. doi: 10.1097/AOG.0000000000005844.
    PubMed     Abstract available
    
    
    
11. SOLOMON MD, Zaritsky EF, Warton M, Millman A, et al
    Effects of the Affordable Care Act on Contraception, Pregnancy, and Pregnancy Termination Rates.
    Obstet Gynecol. 2025;145:196-203.
    PubMed     Abstract available
    
    
    January 2025
12. STEENLAND MW, Oviedo D, Bates MA, Zhou A, et al
    Effect of an Intensive Nurse Home Visiting Program on Postpartum Contraceptive Use and Birth Spacing: A Randomized Controlled Trial.
    Obstet Gynecol. 2025;145:3-12.
    PubMed     Abstract available
    
    
    December 2024
13. FRIEDMAN M, Mor L, Shazar R, Paul N, et al
    Treatment of Early Pregnancy Loss With Mifepristone and Misoprostol Compared With Misoprostol Only.
    Obstet Gynecol. 2024 Dec 5. doi: 10.1097/AOG.0000000000005800.
    PubMed     Abstract available
    
    
    
14. 
    ACOG Committee Statement No. 13: Self-Managed Abortion.
    Obstet Gynecol. 2024;144:e152-e159.
    PubMed     Abstract available
    
    
    November 2024
15. SOLOMON MD, Zaritsky EF, Warton M, Millman A, et al
    Effects of the Affordable Care Act on Contraception, Pregnancy, and Pregnancy Termination Rates.
    Obstet Gynecol. 2024 Nov 1. doi: 10.1097/AOG.0000000000005796.
    PubMed     Abstract available
    
    
    September 2024
16. CASTANO PM
    Postpartum Long-Acting Reversible Contraception: Cost Effectiveness and Patient Desires in a Larger Context.
    Obstet Gynecol. 2024;144:291-293.
    PubMed    
    
    
    August 2024
17. WERNICK HJ, Abdel-Rasoul M, Berlan ED, Bonny AE, et al
    Body Mass Index Changes Among Adolescents and Young Adults Using the Etonogestrel Contraceptive Implant.
    Obstet Gynecol. 2024 Aug 30. doi: 10.1097/AOG.0000000000005712.
    PubMed     Abstract available
    
    
    
18. 
    Rates of Female Sterilization, Vasectomy, and LARC Placement Before and After the Dobbs Decision: A Retrospective Cohort Study [ID 2683404].
    Obstet Gynecol. 2024;144:e46.
    PubMed    
    
    
    July 2024
19. BULLARD KA, Ramanadhan S, Caughey AB, Rodriguez MI, et al
    Immediate Postpartum Long-Acting Reversible Contraception for Preventing Severe Maternal Morbidity: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2024 Jul 25. doi: 10.1097/AOG.0000000000005679.
    PubMed     Abstract available
    
    
    
20. SIMMONS RG, Carter G, Sanders JN, Turok DK, et al
    Assessing Contraceptive Switching and Discontinuation Over 3 Years in the HER Salt Lake Study.
    Obstet Gynecol. 2024;144:79-88.
    PubMed     Abstract available
    
    
    May 2024
21. SIMMONS RG, Carter G, Sanders JN, Turok DK, et al
    Assessing Contraceptive Switching and Discontinuation Over 3 Years in the HER Salt Lake Study.
    Obstet Gynecol. 2024 May 23. doi: 10.1097/AOG.0000000000005621.
    PubMed     Abstract available
    
    
    
22. MEYER R, Toussia-Cohen S, Shats M, Segal O, et al
    24-Hour Compared With 12-Hour Mifepristone-Misoprostol Interval for Second-Trimester Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2024 May 23. doi: 10.1097/AOG.0000000000005535.
    PubMed     Abstract available
    
    
    April 2024
23. MURPHY E, Pelletier A, Fay K, Bartz D, et al
    National Postpartum Permanent Contraception Practices and Perceived Barriers.
    Obstet Gynecol. 2024 Apr 16. doi: 10.1097/AOG.0000000000005584.
    PubMed     Abstract available
    
    
    February 2024
24. 
    Permanent Contraception: Ethical Issues and Considerations: ACOG Committee Statement No. 8.
    Obstet Gynecol. 2024;143:e31-e39.
    PubMed     Abstract available
    
    
    January 2024
25. BAUERFEIND A, von Stockum S, Boehnke T, Heinemann K, et al
    Venous Thromboembolic Risk of Estradiol Valerate-Dienogest Compared with Ethinyl Estradiol-Levonorgestrel Combined Oral Contraceptives.
    Obstet Gynecol. 2024 Jan 16. doi: 10.1097/AOG.0000000000005509.
    PubMed     Abstract available
    
    
    
26. KRASHIN JW, Black P, Brannen E, Gard CC, et al
    Geographic Access to Early Pregnancy Loss Management.
    Obstet Gynecol. 2024 Jan 11. doi: 10.1097/AOG.0000000000005505.
    PubMed     Abstract available
    
    
    
27. 
    ACOG Clinical Consensus No. 3: General Approaches to Medical Management of Menstrual Suppression: Correction.
    Obstet Gynecol. 2024;143:e20.
    PubMed    
    
    
    December 2023
28. IZATT A, Greenberg RA, Thorne J, Erdman J, et al
    Ethical and Legal Considerations for Sterilization Refusal in Nulliparous Women.
    Obstet Gynecol. 2023;142:1316-1321.
    PubMed     Abstract available
    
    
    
29. MITCHELL L, Vellanki B, Tang L, Hunter K, et al
    Contraceptive Provision to Women With Intellectual and Developmental Disabilities Enrolled in Medicaid.
    Obstet Gynecol. 2023;142:1477-1485.
    PubMed     Abstract available
    
    
    
30. MITCHELL L, Vellanki B, Tang L, Hunter K, et al
    Contraceptive Provision to Women With Intellectual and Developmental Disabilities Enrolled in Medicaid.
    Obstet Gynecol. 2023;142:1477-1485.
    PubMed     Abstract available
    
    
    November 2023
31. RAMANADHAN S, Jensen J
    The Levonorgestrel-Releasing Intrauterine Device as Emergency Contraception: Re-examining the Data.
    Obstet Gynecol. 2023 Nov 21. doi: 10.1097/AOG.0000000000005466.
    PubMed     Abstract available
    
    
    
32. ALLEN RH, Bartz D
    Opill: The Over-the-Counter Contraceptive Pill.
    Obstet Gynecol. 2023 Nov 9. doi: 10.1097/AOG.0000000000005455.
    PubMed     Abstract available
    
    
    
33. EBERLE A, Nguyen DB, Smith JP, Mansour FW, et al
    Medical Management of Ovarian Endometriomas: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2023 Nov 9. doi: 10.1097/AOG.0000000000005444.
    PubMed     Abstract available
    
    
    October 2023
34. MITCHELL L, Vellanki B, Tang L, Hunter K, et al
    Contraceptive Provision to Women With Intellectual and Developmental Disabilities Enrolled in Medicaid.
    Obstet Gynecol. 2023 Oct 26. doi: 10.1097/AOG.0000000000005421.
    PubMed     Abstract available
    
    
    
35. HENKEL A, Miller HE, Zhang J, Lyell DJ, et al
    Prior Cesarean Birth and Risk of Uterine Rupture in Second-Trimester Medication Abortions Using Mifepristone and Misoprostol: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2023 Oct 26. doi: 10.1097/AOG.0000000000005259.
    PubMed     Abstract available
    
    
    
36. 
    Association of the Cervicovaginal Microbiome With Contraceptive Methods in Hispanic Women Living in Puerto Rico [ID: 1376364]: Correction.
    Obstet Gynecol. 2023;142:996.
    PubMed    
    
    
    September 2023
37. BULLINGTON BW, Berg KA, Miller ES, Boozer M, et al
    Association Among Race, Ethnicity, Insurance Type, and Postpartum Permanent Contraception Fulfillment.
    Obstet Gynecol. 2023 Sep 7. doi: 10.1097/AOG.0000000000005328.
    PubMed     Abstract available
    
    
    August 2023
38. DARNEY BG, Biel FM, Oakley J, Coleman-Minahan K, et al
    Contraceptive Method Switching and Long-Acting Reversible Contraception Removal in U.S. Safety Net Clinics, 2016-2021.
    Obstet Gynecol. 2023 Aug 3. doi: 10.1097/AOG.0000000000005277.
    PubMed     Abstract available
    
    
    
39. FASSETT MJ, Reed SD, Rothman KJ, Pisa F, et al
    Risks of Uterine Perforation and Expulsion Associated With Intrauterine Devices.
    Obstet Gynecol. 2023 Aug 3. doi: 10.1097/AOG.0000000000005299.
    PubMed     Abstract available
    
    
    July 2023
40. MOSESON H, Jayaweera R, Egwuatu I, Grosso B, et al
    Effectiveness of Self-Managed Medication Abortion Between 9 and 16 Weeks of Gestation.
    Obstet Gynecol. 2023 Jul 6. doi: 10.1097/AOG.0000000000005266.
    PubMed     Abstract available
    
    
    
41. 
    Medicaid and Fulfillment of Postpartum Permanent Contraception Requests: Correction.
    Obstet Gynecol. 2023;142:221-222.
    PubMed    
    
    
    
42. 
    Increasing Access to Intrauterine Devices and Contraceptive Implants: ACOG Committee Statement No. 5: Correction.
    Obstet Gynecol. 2023;142:221.
    PubMed    
    
    
    May 2023
43. VALERIE F
    Where Do We Stand With Mifepristone in the United States?: Making Sense of the Madness.
    Obstet Gynecol. 2023 May 24. doi: 10.1097/AOG.0000000000005253.
    PubMed    
    
    
    
44. QURESHEY EJ, Ibarra CJ, Wagner SM, Chen HY, et al
    Effect of a Multimedia Educational Tool on Contraception Use 1 Year Postpartum.
    Obstet Gynecol. 2023 May 4. doi: 10.1097/AOG.0000000000005198.
    PubMed     Abstract available
    
    
    
45. ARORA KS, Chua A, Miller E, Boozer M, et al
    Medicaid and Fulfillment of Postpartum Permanent Contraception Requests.
    Obstet Gynecol. 2023;141:918-925.
    PubMed     Abstract available
    
    
    
46. NEBLETT MF 2ND, Stewart EA
    Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas.
    Obstet Gynecol. 2023;141:901-910.
    PubMed     Abstract available
    
    
    April 2023
47. PEARLMAN SHAPIRO M, Myo M, Chen T, Nathan A, et al
    Remote Provision of Medication Abortion and Contraception Through Telemedicine.
    Obstet Gynecol. 2023 Apr 13. doi: 10.1097/AOG.0000000000005205.
    PubMed     Abstract available
    
    
    
48. CREININ MD, Jensen JT, Chen MJ, Black A, et al
    Combined Oral Contraceptive Adherence and Pregnancy Rates.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005155.
    PubMed     Abstract available
    
    
    
49. CREININ MD, Barnhart KT, Gawron LM, Eisenberg D, et al
    Heavy Menstrual Bleeding Treatment With a Levonorgestrel 52-mg Intrauterine Device.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005137.
    PubMed     Abstract available
    
    
    
50. CHEN BA, Kimble T, Harris LH, Kerns JL, et al
    Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005147.
    PubMed     Abstract available
    
    
    
51. SUZUKI Y, Chen L, Hou JY, St Clair CM, et al
    Systemic Progestins and Progestin-Releasing Intrauterine Device Therapy for Premenopausal Patients With Endometrial Intraepithelial Neoplasia.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005124.
    PubMed     Abstract available
    
    
    
52. 
    Increasing Access to Intrauterine Devices and Contraceptive Implants: ACOG Committee Statement No. 5.
    Obstet Gynecol. 2023;141:866-872.
    PubMed     Abstract available
    
    
    March 2023
53. SCHWARTZ BI, Bear B, Short VL, Kazak AE, et al
    Outcomes of Menstrual Management Use in Transgender and Gender-Diverse Adolescents.
    Obstet Gynecol. 2023 Mar 9. doi: 10.1097/AOG.0000000000005123.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Contraception and Contraceptive Drugs is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum